Credit Suisse Upgrades Core Laboratories (CLB) to Outperform

August 24, 2017 5:11 AM EDT
Get Alerts CLB Hot Sheet
Price: $26.02 +0.54%

Rating Summary:
    9 Buy, 13 Hold, 7 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 9 | New: 42
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Credit Suisse upgraded Core Laboratories (NYSE: CLB) from Neutral to Outperform with a price target of $110.00.

Analyst Greg Lewis says the sell-off provides an attractive level to accumulate shares. The analyst believes the premium valuation is warranted and expects the company to generate upwards of $92 million in FCF in 2017 which is a CF yield of 2.3%. Lewis expects the Production Enhancement revenue to move higher citing benefits from increased product sales of completions equipment tied to more complex well completions.

For an analyst ratings summary and ratings history on Core Laboratories click here. For more ratings news on Core Laboratories click here.

Shares of Core Laboratories closed at $90.15 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Upgrades

Related Entities

Credit Suisse